Roche to buy U.S. biotech firm Seragon for up to $1.7 billion

[admin]

ZURICH (Reuters) - Roche Holding AG said it would pay up to $1.725 billion to buy Seragon Pharmaceuticals, a privately-held U.S. biotech company that researches breast cancer treatments.



More...